价格

B-10

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
EP 4309736 A3申请人: GILEAD SCIENCES INC优先权: 2014
EP
US
WO
11 件公开
10-(DI(PHENYL)METHYL)-4-HYDROXY-8,9,9A,10-TETRAHYDRO-7H-PYRROLO[1',2':4,5]PYRAZINO[1,2-B]PYRIDAZINE-3,5-DIONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ORTHOMYXOVIRUS REPLICATION FOR TREATING INFLUENZA
EP 3759113 B1申请人: NOVARTIS AG优先权: 2018
CN
EP
US
WO
8 件公开
SODIUM (2R, 5S, 13AR) -7, 9-DIOXO-10- ( (2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1',2' : 4.5] PYRAZINO [2, 1-B] OXAZEPIN-8-OLATE
EP 4523758 A3申请人: GILEAD SCIENCES INC优先权: 2014
CN
EP
US
6 件公开
NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10- {4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15 -(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ONE
EP 3953334 B1申请人: BRISTOL MYERS SQUIBB CO优先权: 2019
EP
US
WO
6 件公开
Internal olefin sulfonate composition
US 9789045 B2申请人: KAO CORP优先权: 2013
CN
EP
US
5 件公开
Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide
US 7119197 B2申请人: PORTELA & CA SA优先权: 2001
CN
US
5 件公开
Oral composition
- US 12029746 B2
  申请人: KAO CORP优先权: 2018
  CN
  EP
  US
  WO
  4 件公开
- US 20260107962 A1
  申请人: KAO CORP优先权: 2022
  CN
  EP
  US
  WO
  4 件公开
- US 20260108487 A1
  申请人: KAO CORP优先权: 2022
  CN
  EP
  US
  WO
  4 件公开
- WO 2025254108 A1
  申请人: KAO CORP优先权: 2024
  WO
- WO 2025254109 A1
  申请人: KAO CORP优先权: 2024
  WO
A PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B] [1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE
EP 4225757 A1申请人: BRISTOL MYERS SQUIBB CO优先权: 2020
CN
EP
US
WO
4 件公开
Method for chiral inversion of (S)-(+)-and (R)-()-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
US 7999100 B2申请人: BIAL PORTELA CA & S A优先权: 2004
CN
US
4 件公开
Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide
US 7241886 B2申请人: PORTELA & CA SA优先权: 2001
CN
US
3 件公开

药物

B-10

专利

Oral composition